{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:28:44Z","timestamp":1793744924408,"version":"4.6.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.gore.2026.102216","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:33:26Z","timestamp":1790098406000},"page":"102216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Docetaxel for recurrent adult granulosa cell tumor enabling tertiary cytoreduction"],"prefix":"10.1016","volume":"67","author":[{"given":"Maryam","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine Jane C.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gore.2026.102216_bb0005","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ygyno.2021.07.024","article-title":"A phase 2 study of anastrozole in patients with oestrogen receptor and\/progesterone receptor positive recurrent\/metastatic granulosa cell tumours\/sex-cord stromal tumours of the ovary: the PARAGON\/ANZGOG 0903 trial","volume":"163","author":"Banerjee","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.gore.2026.102216_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122998","article-title":"Response to systemic therapies in ovarian adult granulosa cell tumors: a literature review","volume":"14","author":"Brink","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.gore.2026.102216_bb0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2024.09.002","article-title":"Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent chemonaive stromal ovarian tumors: an NRG oncology\/gynecologic oncology group study14","volume":"190","author":"Brown","year":"2024","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.gore.2026.102216_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2015.11.027","article-title":"A phase II study of paclitaxel for the treatment of ovarian stromal tumors: an NRG oncology\/ gynecologic oncology group study","volume":"140","author":"Burton","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.gore.2026.102216_bb0025","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1210\/endo.134.5.7908872","article-title":"The inhibitory action of taxol on granulosa cell steroidogenesis is reversible","volume":"134","author":"Chen","year":"1994","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.gore.2026.102216_bb0030","doi-asserted-by":"crossref","first-page":"724.e1","DOI":"10.1016\/j.ajog.2023.02.029","article-title":"Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors","volume":"228","author":"Foster","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7\u20138","key":"10.1016\/j.gore.2026.102216_bb0035","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000341078","article-title":"Complete response in a patient with granulosa cell tumor treated with a combination of leuprolide and tamoxifen","volume":"35","author":"Keskin","year":"2012","journal-title":"Onkologie"},{"issue":"5","key":"10.1016\/j.gore.2026.102216_bb0040","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/ijgc-00009577-200309000-00018","article-title":"Effective weekly docetaxel for recurrent ovarian cancer: a case report","volume":"13","author":"Komiyama","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.gore.2026.102216_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2013.04.047","article-title":"Recurrent granulosa cell tumors (GCTs) of the ovary: a MITO-9 retrospective study","volume":"130","author":"Mangili","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2026.102216_bb0050","article-title":"Long-term efficacy of megestrol acetate and tamoxifen in a recurrent adult granulosa cell tumor of the ovary","volume":"36","author":"Moon","year":"2021","journal-title":"Gynecol. Oncol. Rep."},{"issue":"4","key":"10.1016\/j.gore.2026.102216_bb0055","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jnci\/83.4.288","article-title":"Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol","volume":"83","author":"Ringel","year":"1991","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.gore.2026.102216_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2026.01.008","article-title":"New therapeutic strategies for relapsed adult type ovarian granulosa cell tumors: from discovery to clinical progress","author":"Rothschild","year":"2026","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.gore.2026.102216_bb0065","first-page":"419","article-title":"Successful response to docetaxel treatment in recurrent ovarian granulosa cell tumor: a case report","volume":"33","author":"Shavit","year":"2012","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"1","key":"10.1016\/j.gore.2026.102216_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000274590","article-title":"Nearly 30 years of treatment for recurrent granulosa cell tumor of the ovary: a case report and review of the literature","volume":"3","author":"Teoh","year":"2010","journal-title":"Case Rep. Oncol."},{"issue":"3","key":"10.1016\/j.gore.2026.102216_bb0075","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/IGC.0000000000000077","article-title":"Effectiveness of chemotherapy in measurable granulosa cell tumors: a retrospective study and review of literature","volume":"24","author":"van Meurs","year":"2014","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926001967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926001967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:01:36Z","timestamp":1793743296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578926001967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":15,"alternative-id":["S2352578926001967"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2026.102216","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Docetaxel for recurrent adult granulosa cell tumor enabling tertiary cytoreduction","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2026.102216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102216"}}